Halozyme’s Patent Win Over Merck Changes Future Deals
A Dutch court order restricting Keytruda SC in eight markets boosts Halozyme’s leverage.
A Dutch court order restricting Keytruda SC in eight markets boosts Halozyme’s leverage.
CVX is handing back its Hess Midstream stake and DJ Basin assets for cheaper long-term contracts. HESM units are the…
Trump's red-dyed diesel order is real but temporary, and the question for investors is whether refiners earn the trade or…
Kone’s planned sale of most of TK Elevator’s European business shows why the service book, not the machinery, is the…
Viking Global tripled its stake. Renaissance added $546M. Q2 13F filings show Amazon as a major accumulation story heading into…
Investment banking fees up 30% in Q2, and management is guiding for more. Bank of America told a very different…
The Brakebush deal makes strategic sense, but income investors should watch leverage through fiscal 2027.
The FAA’s MAX 10 delay over a VNAV software issue raises 2027 delivery risk and complicates Boeing’s $10 billion free…
With $15.3 trillion in AUM and a $400 billion private markets target, BLK is not just riding the tokenization wave…
Morgan Stanley's new OTA rankings use engagement data, and Expedia's 0% user growth is a warning sign.